Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA.
Department of Otolaryngology, Head and Neck Surgery, Faculty of Medicine in Rabigh, King Abdulaziz University, Jeddah, Saudi Arabia.
Otol Neurotol. 2021 Jan;42(1):108-115. doi: 10.1097/MAO.0000000000002876.
Endoscopic ear surgery (EES) has been increasingly adopted to enhance visualization during otologic surgery including pediatric cholesteatoma resection. The purpose of this study is to systematically review the current literature reporting rates of residual cholesteatoma to evaluate outcomes of EES in the pediatric population.
PubMed, Embase, Cochrane.
Using the Preferred Reporting Items for Systematic Reviews and Meta-Analysis recommendations (PRISMA), we systematically reviewed studies that reported outcomes for cholesteatoma surgery in children using the endoscope. Studies were included if they described the use of the endoscope for middle ear surgery and measured outcomes following cholesteatoma resection in pediatric patients.
Identified articles were assessed for study design, sample size, inclusion of pediatric population, the presence of a comparison group, outcomes measured such as: residual disease rate, recurrent cholesteatoma, audiologic outcome, quality of life measures, and complications.
Fourteen articles in the literature discussed cholesteatoma outcomes in children when the endoscope was employed. Residual disease rate ranged from 0 to 22% when endoscope was used for dissection compared with 11 to 55% when endoscope was used for inspection or not at all. A meta-analysis was conducted on 11 studies. There was a significant risk reduction in residual disease rates for endoscopic dissection when compared with microscope (RR = 0.48, 95% CI = 0.37-0.63, p < 0.001).
Among the studies included in this review, EES was associated with lower rates of residual cholesteatoma compared with traditional microscopic techniques. Additional prospective studies are needed to further assess these findings.
内镜耳部手术(EES)已越来越多地被采用,以增强耳科学手术中的可视化效果,包括小儿胆脂瘤切除术。本研究的目的是系统地回顾目前报道残留胆脂瘤发生率的文献,以评估 EES 在儿科人群中的结果。
PubMed、Embase、Cochrane。
使用系统评价和荟萃分析的首选报告项目(PRISMA),我们系统地回顾了使用内镜报告儿童胆脂瘤手术结果的研究。如果研究描述了内镜在中耳手术中的应用,并测量了小儿患者胆脂瘤切除术后的结果,则纳入研究。
评估了确定的文章的研究设计、样本量、儿科人群的纳入情况、是否存在对照组、测量的结果,如残留疾病率、复发性胆脂瘤、听力结果、生活质量测量和并发症。
文献中有 14 篇文章讨论了内镜应用于儿童胆脂瘤的结果。与内镜用于检查或根本不用于检查时的 11%至 55%相比,内镜用于解剖时残留疾病的发生率为 0 至 22%。对 11 项研究进行了荟萃分析。与显微镜相比,内镜解剖的残留疾病发生率显著降低(RR=0.48,95%CI=0.37-0.63,p<0.001)。
在本综述纳入的研究中,EES 与传统显微镜技术相比,残留胆脂瘤的发生率较低。需要进一步的前瞻性研究来进一步评估这些发现。